Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Sandoparin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Heparin, Low-Molecular-Weight

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Pitfalls in patient self-management of subcutaneous drug application: removal of rubber protection caps from ready-to-use syringes
Outpatient subcutaneous therapies are becoming more and more common, such as the use of low-molecular-weight heparins (LMWH) for… Expand
  • figure 1
2009
2009
“Heparin Allergy” Secondary to Preservative, Namely Benzyl Alcohol
Heparin is an injectable anticoagulant that prevents coagulation. There are presently high and low molecular heparins as well as… Expand
2005
2005
Prevention of deep vein thrombosis in patients with hip fractures: Low molecular weight heparin versus dextran
A randomized open trial was undertaken to compare the antithrombotic efficacy of a low molecular weight heparin (LMWH; Sandoparin… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2004
2004
Wirksamkeit und Sicherheit niedermolekularer Heparine
  • A. Encke
  • Langenbecks Archiv für Chirurgie
  • 2004
    • Corpus ID: 28145869
Niedermolekulare Heparine (NMH) werden aus unfraktioniertem Heparin dutch Gelchromatographie, Alkoholf/illung oder enzymatische… Expand
1995
1995
Delayed hypersensitivity to one low‐molecular‐weight heparin with tolerance of other low‐molecular‐weight heparins
We report a patient who developed infiltrated plaques at the sites of subcutaneous injection of a low‐molecular‐weight heparin… Expand
1995
1995
Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.
Recent studies have indicated a beneficial effect of one particular low molecular weight heparin preparation (Fragmin) on lipid… Expand
1993
1993
[Prevention of thromboembolism in hip fracture: unfractionated heparin versus low molecular weight heparin ( a prospective, randomized study)].
In a prospective, randomized study in patients with hip fracture we discuss whether a single dose of low-molecular-heparin… Expand
1992
1992
The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis model.
Since the beginning of the clinical use of low molecular weight (LMW) heparins their thrombolytic or profibrinolytic potency has… Expand
1990
1990
[Perioperative prevention of thromboembolism with low molecular weight heparin and postoperative bleeding complications].
In three studies the effect and secondary effect of low molecular weight heparin (LMWH) were examined. Study 1: LMWH (Embolex-LM… Expand
1990
1990
Perioperative Thromboembolieprophylaxe mit niedermolekularen Heparin und postoperative Blutungskomplikation
In 3 Studien wurden Wirkung und Nebenwirkung von LMW-Heparin untersucht. Studie 1: LMW-Heparin-DHE (Embolex-LM, n = 464) versus… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE